BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 22951239)

  • 1. The transdermal delivery system of monoamine oxidase inhibitors.
    VanDenBerg CM
    J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update.
    Flockhart DA
    J Clin Psychiatry; 2012; 73 Suppl 1():17-24. PubMed ID: 22951238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of monoamine oxidase inhibitors in primary care.
    Culpepper L
    J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of monoamine oxidase inhibitors in depression treatment guidelines.
    Thase ME
    J Clin Psychiatry; 2012; 73 Suppl 1():10-6. PubMed ID: 22951237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAOIs and transdermal delivery.
    Vandenberg CM
    J Clin Psychiatry; 2012 Sep; 73(9):e28. PubMed ID: 23059160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
    Rapaport MH
    J Clin Psychiatry; 2007; 68 Suppl 8():42-6. PubMed ID: 17640157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAOIs and depression treatment guidelines.
    Thase ME
    J Clin Psychiatry; 2012 Jul; 73(7):e24. PubMed ID: 22901357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM; de Leon J
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAOIs: issues in treatment adherence and rates of treatment failure.
    Cohen LJ; Sclar DA
    J Clin Psychiatry; 2013 Jan; 74(1):e02. PubMed ID: 23419230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting monoamine oxidase inhibitors.
    Krishnan KR
    J Clin Psychiatry; 2007; 68 Suppl 8():35-41. PubMed ID: 17640156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
    Cooper AJ
    Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selegiline transdermal system: current awareness and promise.
    Pae CU; Lim HK; Han C; Neena A; Lee C; Patkar AA
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1153-63. PubMed ID: 17614182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient compliance with MAO inhibitor therapy.
    Walker JI; Davidson J; Zung WW
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):78-80. PubMed ID: 6735998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI; Herrmann N; Walker SE
    CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotropic drugs (2). Interaction between monoamine oxidase (MAO) inhibitors and other substances.
    Sjöqvist F
    Proc R Soc Med; 1965 Nov; 58(11 Part 2):967-78. PubMed ID: 4952963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues in adherence to treatment with monoamine oxidase inhibitors and the rate of treatment failure.
    Cohen LJ; Sclar DA
    J Clin Psychiatry; 2012; 73 Suppl 1():31-6. PubMed ID: 22951240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.